The overall objective of this study is to investigate the effects of different types of red wine on markers of endothelial function and platelet aggregation.
Potential participants are provided with information about the study and potential risks. Once participants decided to participate in the study, they will be scheduled for a health screening visit which determines eligibility to the study entry. If participants are eligible, they will be randomized in a three-way crossover study design to receive three interventions (control, red wine1, and red wine2) with the one-week washout period. On the study day, participants will be assessed for baseline measurements, provided with the designated beverage, and followed up for the measurements at 2 and 4 hours after the consumption.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
10
8 oz (237 ml) of red wine A and red wine B will be blinded and randomized between Japanese Zweigelt red wines from vintages 2015 or 2018.
8 oz (237 ml) of red wine A and red wine B will be blinded and randomized between Japanese Zweigelt red wines from vintages 2015 or 2018.
8 oz (237 ml) of control beverage is a beverage that has similar calories to red wines.
Ragle Human Nutrition Research Center
Davis, California, United States
Peripheral Arterial Tonometry (PAT)
Endothelial function
Time frame: Baseline
Peripheral Arterial Tonometry (PAT)
Endothelial function
Time frame: 2 hours after beverage consumption
Peripheral Arterial Tonometry (PAT)
Endothelial function
Time frame: 4 hours after beverage consumption
Platelet Aggregation
Light Transmission Aggregometry
Time frame: Baseline and 2 and 4 hours after beverage consumption
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.